EP3949952
PHARMACEUTICAL COMPOSITION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.4.2020EP published:
17.7.2024EP application number:
20784888.8
EPO information:
European Patent Register
Max expiry date:
1.4.2040
Title in English:
PHARMACEUTICAL COMPOSITIONLanguage of the patent:
English
Timeline
Today
2.4.2020EP application
17.7.2024EP Publication
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Inventor
Name:
SASAKI AkihikoAddress:
Tokyo 103-8411, JP
Name:
TANAKA KoAddress:
Tokyo 103-8411, JP
Name:
MIYAZAKI MasakazuAddress:
Tokyo 103-8411, JP
Name:
TAKAE SeijiAddress:
Tokyo 103-8411, JP
Priority
Number:
2019070997Date:
3.4.2019Country:
JP
Classification
Categories:
A61K 9/20, A61K 47/22, A61K 47/26, A61K 47/46, A61K 31/497, A61K 9/00, A61K 9/16